Kentucky Society of Health-System Pharmacists presents their 2011 Fall Meeting September 15-16, 2011 Lexington, Kentucky Crowne Plaza Hotel – The Campbell House 1375 Harrodsburg Road • Lexington, KY 40504 859-255-4281 Kentucky Society of Health-System Pharmacists 1501 Twilight Trail • Frankfort, KY 40601 (502) 223-5322 • Fax (502) 223-4937 www.kshp.org • [email protected] Sullivan University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Sullivan University College of Pharmacy designates this activity for up to 0.9 CEUs (9 contact hours) of continuing education for pharmacists. Except where specifically noted, all sessions are designated as knowledge-based learning activities. Except where specifically otherwise noted in the program, Sullivan University College of Pharmacy is the provider for continuing education at this symposium. Continuing education for one topic during day one of the symposium, so noted following the course description section of this program, is provided by the University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC. That program is designated as providing 0.1 CEU (1 contact hour) of knowledge-based continuing education for pharmacists. The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Faculty Disclosure In accordance with the Accreditation Council for Pharmacy Education (ACPE) Accreditation Standards for Continuing Pharmacy Education and the policy of Sullivan University College of Pharmacy faculty disclosure of any relevant financial relationships with commercial entities must be given prior to presentations. Full disclosure was not available at the time of printing. Disclosure will be given verbally prior to each presentation. CPE statements of credit will be distributed via email to symposium registrants who attend the live program and complete on-line course evaluations for each session attended. The deadline for submitting on-line course evaluations will be September 30, 2011. Continuing education statements of credit will be distributed within 30 days after course evaluations deadline. Attendees without e-mail may request their CPE statement of credit be sent to them via U.S. Postal Service mail. Registration Deadline is August 31, 2011 This is a GREEN meeting. We will not be printing anything for the meeting. Please bring this agenda with you to the meeting. Kentucky Society of Health System Pharmacists 2011 Fall Meeting *Program subject to changes Thursday, September 15, 2011 7:45 am – 8:15 am Registration and Continental Breakfast 8:15 am – 8:30 am President’s Welcome 8:30 am – 9:30 am COPD: Pathophysiology, Treatment Options, and Focus on New Drugs J. Randall Thompson, M.D., Baptist Pulmonary & Critical Care Associates, Lexington, KY 0.1 CEUs ACPE# 0617-0000-11-035-L01-P Name the common signs and symptoms of COPD Explain basic pathophysiology of COPD Describe the economic burden of COPD to society List current treatment options for COPD Discuss new medication options for COPD treatment 9:35 am – 10:30 am Management of Pediatric Asthma Adrian O’Hagan, M.D., Assistant Professor of Pediatrics, University of Louisville School of Medicine, Louisville, KY 0.1 CEUs ACPE # 0617-0000-11-036-L01-P Explain the current guidelines for management of asthma Choose appropriate therapy for treatment of pediatric asthma Name the three most common allergic triggers in pediatric asthma List novel therapeutic agents available for treating asthma 10:35 am – 11:15 am Exhibits Open 11:15 am – 12:15 pm Focus on Hyponatremia: Understanding and Treating the Most Common Electrolyte Disorder J. Herbert Patterson, Pharm.D., FCCP, Professor of Pharmacy and Research, Professor of Medicine, Vice Chair for Research and Graduate Education, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, NC; Denise H. Rhoney, Pharm.D., FCCM, FCCP, Associate Professor, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 0.1 CEUs ACPE# 0046-9999-11-116-L01-P Note: Continuing education credit for this session is provided by the University of North Carolina Eshelman School of Pharmacy and Paradigm Medical Communications, LLC. This program is supported by an educational grant from Otsuka America Pharmaceutical. Attendees of this live program who complete an evaluation form will receive their continuing education statements of credit by mail 2-4 weeks following the program. Define and describe the types of hyponatremia, their etiologies and underlying pathophysiologic mechanisms Evaluate treatment strategies for hyponatremia and their appropriateness in specific patient types, especially high risk Describe and address the cost and resource allocation challenges to health systems and pharmacists posed by the diagnosis and treatment of hyponatremia 12:15 pm – 1:15 pm University of Kentucky College of Pharmacy Preceptor Recognition Program (Lunch provided) Join us to learn about our experiential education program as we recognize our past and present preceptors. 1:30 pm – 3:35 pm Breakout sessions This is a GREEN meeting. We will not be printing anything for the meeting. Please bring this agenda with you to the meeting. Thursday, September 15, 2011 (continued) 1:30 pm – 2:30 pm Toxicologic Emergencies: A Brief Update on Management Stephanie Baker, Pharm.D., BCPS, Emergency Medicine Clinical Pharmacy Specialist, University of Kentucky HealthCare, Lexington, KY 0.1 CEUs ACPE# 0617-0000-11-021-L01-P Describe the controversy associated with intravenous N-acetylcysteine dosing in the setting of acetaminophen overdose in obese patients List three advantages of fomepizole over ethanol in the treatment of a toxic ethylene glycol and/or methanol ingestion Explain the role of both the non-pharmacologic and pharmacologic management strategies for carbon monoxide poisoning Discuss the mechanism of action of octreotide as it pertains to its role in the treatment of patients who present with a suspected sulfonylurea ingestion Identify the way insulin and euglycemia can serve as an antidote in the management of beta- blocker and calcium channel blocker toxidrome 1:30 pm – 2:30 pm Do It, Document, It, Teach It: Enhancing Your Documentation and Precepting Skills (Part 1) Anne Policastri, Pharm.D, MBA, FKSHP, Assistant Director of Experiential Education, University of Kentucky College of Pharmacy, Lexington, KY Holly Divine, Pharm.D., CGP, CED, FAPhA, Clinical Associate Professor, University of Kentucky College of Pharmacy, Lexington, KY 0.2 CEUs (Parts 1 + 2) ACPE# 0617-0000-11-023-L04-P Note: This is an application-based learning activity Identify key components in documenting patient care activities Review formats and importance of pharmacy related documentation Document various pharmacists’ interventions through case examples Discuss applications for training pharmacists, students, and residents 2:35 pm – 3:35 pm Do It, Document, It, Teach It: Enhancing Your Documentation and Precepting Skills (Part 2) (Attendees must participate in both Part 1 and 2 to receive CE credit) 2:35 pm – 3:35 pm Palliative Care: Focus on Role of Pharmacists Todd Coté, MD, FAAFP, FAAHPM, Program Director: University of Kentucky College of Medicine and Hospice of the Bluegrass Fellowship in Hospice and Palliative Medicine 0.1 CEUs ACPE# 0617-0000-11-033-L01-P Explain the difference between palliative care and hospice care Describe the potential roles for pharmacists in palliative care Defend the right of palliative care patients to effective pain and symptom management 3:35 pm – 4:00 pm Exhibit and Refreshment Break 4:00 pm – 5:00 pm Pearls Presentations (Room 1) U-500 Insulin Maggie Mangino, Pharm.D., Ambulatory/Wellness Clinical Pharmacist Specialist, Norton Healthcare Pharmacy Services, Louisville, KY 0.025 CEUs ACPE# 0617-0000-11-030-L01-P Explain the clinical uses of U-500 regular insulin Identify the primary safety concerns in using U-500 insulin and explain strategies to reduce potential medication errors This is a GREEN meeting. We will not be printing anything for the meeting. Please bring this agenda with you to the meeting. Thursday, September 15, 2011 (continued) Modern Marvels or Same Old Stuff: The Protease Inhibitors for Hepatitis C Jennifer Hibbs, Pharm.D., BCPS, Assistant Professor Solid Organ Transplant Specialist, Sullivan University College of Pharmacy 0.025 CEUs ACPE# 0617-0000-11-029-L01-P Describe the current role of telaprevir and boceprevir in the treatment of Hepatitis C virus Identify common drug interactions, contraindications and major medication dosing requirements for these agents Rheumatoid Arthritis – It Isn’t Just Bad Joints Barbara Jolly, R.Ph, MPA, Associate Professor and Director, Office of Lifelong Professional Development, Sullivan University College of Pharmacy, Louisville, KY 0.025 CEUs ACPE# 0617-0000-11-024-L01-P List 5 non-articular aspects of rheumatoid arthritis (RA) Identify common drugs responsible for drug-related lung disease in RA Name bacterial, fungal and viral infections associated with TNF-alpha inhibitor therapy Therapeutic Hypothermia: Supportive Therapy and the Pharmacist Amy Weir, Pharm.D., Critical Care Specialist, Central Baptist Hospital, Lexington, KY 0.025 CEUs ACPE# 0617-0000-11-032-L01-P State the current recommendations